Bobiotics
The computed 12-month bankruptcy probability of Bobiotics is 3.2% (moderate). The 2024 annual accounts show negative equity (€-7k) and a net result of €-8k. Its solvency ranks better than 25% of 6698 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-7k |
| Net result | €-8k |
| Better than sector | 25% |
| Active | 2 yrs |
Mixed profile: strong on profitability, weaker on health.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -4.5% | 20.4% | |
| Net result | €-8k | €4k | |
| Equity | €-7k | €16k | |
| Gross operating margin | €-5k | €24k | |
| Total assets | €155k | €94k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €-5k |
| Net profit | €-8k |
| Cash flow | €-8k |
| Staff costs | - |
| Income taxes | €0 |
| Dividends | - |
| Total assets | €155k |
| Equity | €-7k |
| Debt | €162k |
| of which ≤ 1y | €160k |
| of which > 1y | - |
| Working capital | €-9k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.94 |
| Quick ratio | 0.77 |
| Working capital ratio | -6.0% |
| Solvency | -4.5% |
| Debt / equity | -23.23 |
| Long-term debt ratio | - |
| Interest coverage | -1.85 |
| Gross margin | - |
| Net margin | - |
| ROA | -5.0% |
| ROE | 110.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €155k |
| Fixed assets | 21/28 | €4k |
| Intangible fixed assets | 21 | €4k |
| Current assets | 29/58 | €151k |
| Stocks & contracts in progress | 3 | €28k |
| Amounts receivable within one year | 40/41 | €18k |
| Cash & bank | 54/58 | €41k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €155k |
| Equity | 10/15 | €-7k |
| Contributions / capital | 10/11 | €2 |
| Accumulated profits (losses) | 14 | €-7k |
| Amounts payable | 17/49 | €162k |
| Amounts payable within one year | 42/48 | €160k |
| Trade debts payable within one year | 44 | €71k |
| Income statement | ||
| Gross operating margin | 9900 | €-5k |
| Operating result | 9901 | €-5k |
| Financial charges | 65 | €3k |
| Result before taxes | 9903 | €-8k |
| Income taxes | 67/77 | €0 |
| Net result for the period | 9904 | €-8k |
| Result to be appropriated | 9905 | €-8k |
Former directors (2)
-
Former- → 14-03-2025
-
Former- → 14-03-2025
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| AUDITAS BEDRIJFSREVISOREN BVCurrent Company auditor · represented by Sven Vansteelant |
- | 14-03-2025 → present |
| NACE primary | Overige niet-gespecialiseerde detailhandel(47120) |
| Legal form | Private limited company(610) |
| Incorporation | 23-10-2023 |
| Status | Active |
| Postal code | 9050 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44032A0120/00G007 | Flanders | 117 m² | 1 · 74 m² | 10.8 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
23-12-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-11-20",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "1001.495.603",
"name_full": "BOBIOTICS",
"legal_form": "BV"
},
"signature_regime": "joint_two",
"special_mandates": [
{
"quote": "De algemene vergadering besluit de opdracht te geven aan de ondergetekende notaris om de co\u00F6rdinatie van de statuten op te maken en te ondertekenen, in overeenstemming met het vorige besluit, en de neerlegging daarvan in het vennootschapsdossier te verzorgen.",
"holder_kbo": null,
"holder_name": "Meester Barbara Balliere",
"scope_categories": [
"publication",
"filing",
"statute_coordination"
],
"with_substitution": false
},
{
"quote": "De vergadering verleent bijzondere volmacht aan elke bestuurder, allen individueel bevoegd, met mogelijkheid tot indeplaatsstelling alle administratieve handelingen en formaliteiten te vervullen met betrekking tot de genomen besluiten, zoals, doch zonder beperkend te zijn, de wijziging van de inschrijving in de Kruispuntbank van Ondernemingen en, desgevallend, de wijziging van de btw-identificatie.",
"holder_kbo": null,
"holder_name": "Elke bestuurder, allen individueel bevoegd",
"scope_categories": [
"administrative_formalities",
"KBO",
"tax"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}25-03-2025 Capital increase of €80,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 80000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 80000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-03-14",
"evidence_quote": "De vergadering besluit vervolgens tot een inbreng in geld, ten belope van tachtigduizend euro (\u20AC 80.000,00), door uitgifte van vierhonderdachtenveertig (448) nieuwe aandelen.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1001.495.603",
"name_full": "GAVE DIGITAL BUSINESS",
"legal_form": "VOF"
}
}25-10-2023 Incorporation of a new VOF
Technical details
{
"kind": "oprichting",
"seat": "Edmond Van Hoorebekestraat 100, 9050 Gent",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1997-01-18",
"name": "GALLIN Gauthier",
"niss": null,
"address": "Heilige-Geeststraat 2, 9000 Gent"
},
"share_class": "naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": "GALLIN Gauthier",
"is_subscriber_only": false,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 1,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1996-03-14",
"name": "VERSCHELDEN Lowie",
"niss": null,
"address": "Edmond Van Hoorebekestraat 100, 9050 Ledeberg"
},
"share_class": "naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": "VERSCHELDEN Lowie",
"is_subscriber_only": false,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 1,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2,
"subject_company": {
"kbo": "1001.495.603",
"name_full": "GAVE Digital Business",
"legal_form": "VOF"
},
"initial_directors": [],
"incorporation_date": "2023-10-16",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Bobiotics |